2-(4-Bromo-2-fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

1-(4-METHYLTHIAZOL-2-YL)ETHANAMINE 2HCL, 95.0%, 1g

5-Phenyl-1,3,4-oxadiazol-2-amine, 95.0%, 25g

tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate, 95.0%, 10g

1-Ethylazepane, 98%, 250mg

7-Amino-2,3-dihydroinden-1-one, 95.0%, 1g

Methyl 3-amino-2-chloro-4-methylbenzoate, 95%, 100mg

(2R,3S,4R,5R,6S)-5-amino-4-(benzyloxy)-2-((benzyloxy)methyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3-ol, 98%, 100mg

4,4'-DITHIOBISBENZOIC ACID, 95%, 100mg

N-(5-((4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)((4-methyl-3-(5-(thiophen-2-yl)nicotinamido)benzoyl)oxy)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide, 97%, 25mg

Viales de muestra ROTILABO® con rosca corta ND9, PP transparente, con graduaciones, 1,5 ml, 100 Unidad(es)

4-Propylpyridine, 95.0%, 5g

benzyl 3-({[(tert-butoxy)carbonyl]amino}methyl)-3-hydroxyazetidine-1-carboxylate, 97.0%, 1g